COLL
NASDAQ · Pharmaceuticals
Collegium Pharmaceutical Inc
$37.80
-1.53 (-3.89%)
Open$39.65
Previous Close$39.33
Day High$40.50
Day Low$37.61
52W High$50.79
52W Low$26.72
Volume—
Avg Volume509.1K
Market Cap1.23B
P/E Ratio19.51
EPS$1.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+27.4% upside
Current
$37.80
$37.80
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 638.07M | 536.47M | 486.77M |
| Net Income | 51.39M | 38.89M | 68.71M |
| Profit Margin | 8.1% | 7.7% | 14.1% |
| EBITDA | 137.19M | 109.57M | 134.63M |
| Free Cash Flow | — | — | 97.48M |
| Rev Growth | +18.9% | +18.9% | +18.7% |
| Debt/Equity | 2.68 | 2.68 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |